Since miR-34a targets include the anti-apoptotic protein Bcl-2, baculoviral IAP repeat-containing 3 (BIRC3) and decoy receptor 3 (DcR3), the combined effects of upregulating p53 and downregulating miR-34a targets strongly enhance cancer cell death [20,60–62]. This evidence concerns the gene BCL2 and cancer.